… anti-atherosclerotic therapy, we have designed an algorithm of the development of anti-cytokine
therapy for atherosclerosis prevention, that includes screening of anti-cytokine activity of …

… cell targeting, anti-cytokine and anti-chemokine strategies to better treat atherosclerosis we
… contribute to development and progression of atherosclerosis, their cellular interactions and …

… optimal drug treatment, in the same group, anti-cytokine therapy can … prevention of
atherosclerosis. There is a rather urgent need to explore the possibility of further developing …

… in the prevention and treatment of cardiovascular disease. Cytokines involved in human …
atherosclerosis, the potential benefits and risks associated with targeted anticytokine therapies, …

… application of anti-inflammatory therapies for the prevention of atherosclerosis-related events
(… assessment of patient suitability for anti-cytokine therapy, due to the overriding concern of …

… (Tregs) attenuate atherosclerosis, but their therapeutic application by adoptive … treatment
to expand Tregs and inhibit both the progression and development of developed atherosclerosis…

… inflammatory components contribute to the atherosclerotic process, several cytokines and …
their effect in preventing atherosclerosis. Herein we discuss the available therapeutic options …

… of new therapeutic targets, offering promising perspectives for the treatment and prevention
of atherosclerosis. … treatment approaches for atherosclerotic cardiovascular diseases. …

… Atherosclerosis and atherothrombosis are the underlying mechanisms for the great majority
… anti-cytokine study and will address the use of canakinumab for secondary prevention of …

… atherosclerosis (AS) is an inflammatory disease and the most common cause of ischemia.
With the progress of basic and clinical research, anti-cytokine therapy has … for AS treatment. …